French drugmaker Sanofi has made a $40 million investment in Gyroscope Therapeutics, with another $20 million potentially on offer as the UK biotech advances its clinical-stage gene therapies for ...
Just a few weeks France's Sanofi made a $40 million investment in Gyroscope for first refusal rights on the gene therapy – called GT005 – but it is Novartis that has swooped on the company and ...
Scientists from the University College London (UCL), the National Oceanography Centre (NOC), and the École Normale Supérieure ...
Persistent Link: https://ieeexplore.ieee.org/servlet/opac?punumber=7361 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback